Vívian T Martins Selected Research

Pyridoxal Kinase

12/2020	Corrigendum to "Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis". Molecular Immunology 124 (2020) 161-171.
1/2020	Evaluation of Leishmania infantum pyridoxal kinase protein for the diagnosis of human and canine visceral leishmaniasis.
1/2020	Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vívian T Martins Research Topics

Disease

32	Visceral Leishmaniasis (Kala Azar) 06/2022 - 04/2016
22	Infections 07/2022 - 01/2016
11	Leishmaniasis 06/2022 - 01/2017
3	Coinfection 12/2021 - 11/2021
2	HIV Infections (HIV Infection) 12/2021 - 11/2021
2	Neglected Diseases 06/2020 - 01/2020
1	Drug-Related Side Effects and Adverse Reactions 02/2022
1	Leprosy (Hansen's Disease) 12/2021
1	Paracoccidioidomycosis (South American Blastomycosis) 12/2021
1	Chagas Disease (American Trypanosomiasis) 12/2021
1	Tuberculosis (Tuberculoses) 12/2021
1	Parasitic Diseases (Parasitic Disease) 02/2021
1	Heart Diseases (Heart Disease) 01/2021
1	Disease Progression 01/2018

Drug/Important Bio-Agent (IBA)

28	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2016
14	VaccinesIBA 06/2022 - 01/2016
8	Recombinant ProteinsIBA 06/2022 - 01/2018
7	AntigensIBA 12/2021 - 01/2018
4	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 06/2022 - 08/2021
4	AntibodiesIBA 01/2022 - 01/2018
4	Recombinant Fusion ProteinsIBA 12/2021 - 01/2017
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2021 - 01/2018
3	Peptides (Polypeptides)IBA 12/2021 - 01/2017
3	EpitopesIBA 11/2021 - 04/2016
3	Interleukin-12 (IL 12)IBA 02/2021 - 10/2018
3	Immunoglobulin G (IgG)IBA 02/2021 - 01/2018
3	SaponinsIBA 02/2021 - 07/2017
3	DNA VaccinesIBA 12/2020 - 01/2018
3	Pyridoxal KinaseIBA 12/2020 - 01/2020
3	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 06/2020 - 10/2018
2	MicellesIBA 07/2022 - 01/2022
2	A-Form DNA (A-DNA)IBA 02/2021 - 01/2019
2	Virulence Factors (Pathogenicity Factors)IBA 02/2021 - 01/2018
2	CardenolidesIBA 01/2021 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 01/2018
2	Synthetic Vaccines (Recombinant Vaccines)IBA 06/2020 - 01/2020
2	Peptide Initiation Factors (Initiation Factor)IBA 01/2020 - 01/2016
2	ProhibitinsIBA 01/2020 - 01/2018
2	NitritesIBA 01/2020 - 01/2018
2	InterferonsIBA 10/2018 - 01/2018
1	SaltsIBA 07/2022
1	quinolineIBA 07/2022
1	EnzymesIBA 06/2022
1	ImmunosorbentsIBA 06/2022
1	NaphthoquinonesIBA 02/2022
1	Poloxamer (Poloxamer 407)IBA 01/2022
1	Guanosine Triphosphate (GTP)IBA 01/2022
1	GTP-Binding Proteins (G-Protein)IBA 01/2022
1	N 30IBA 12/2021
1	Acarbose FDA LinkGeneric 06/2021
1	Pharmaceutical PreparationsIBA 02/2021
1	Ivermectin (Mectizan)FDA Link 02/2021
1	miltefosine (Impavido)IBA 01/2021
1	Digitoxin FDA Link 01/2021
1	DigitoxigeninIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Liposomes (Liposome)IBA 06/2020
1	Leishmania infantum amastin proteinIBA 01/2020
1	Staphylococcal Protein A (Protein A)IBA 12/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2018
1	Amphotericin B (Amphotericin)FDA LinkGeneric 03/2018
1	Adenosine Monophosphate (AMP)IBA 03/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	InterleukinsIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Interleukin-4 (Interleukin 4)IBA 01/2018
1	Glutamine (L-Glutamine)FDA Link 11/2017
1	Phosphopyruvate Hydratase (Enolase)IBA 07/2017
1	PolyproteinsIBA 01/2016

Therapy/Procedure

1	Therapeutics 02/2022
1	Aftercare (After-Treatment) 12/2019
1	Drug Therapy (Chemotherapy) 01/2018